Literature DB >> 23824781

Prognosis and course of disability in patients with chronic nonspecific low back pain: a 5- and 12-month follow-up cohort study.

Karin Verkerk1, Pim A J Luijsterburg, Martijn W Heymans, Inge Ronchetti, Annelies L Pool-Goudzwaard, Harald S Miedema, Bart W Koes.   

Abstract

BACKGROUND: Few data are available on the course of and predictors for disability in patients with chronic nonspecific low back pain (CNSLBP).
OBJECTIVE: The purpose of this study was to describe the course of disability and identify clinically important prognostic factors of low-back-pain-specific disability in patients with CNSLBP receiving multidisciplinary therapy.
DESIGN: A prospective cohort study was conducted.
METHODS: A total of 1,760 patients with CNSLBP who received multidisciplinary therapy were evaluated for their course of disability and prognostic factors at baseline and at 2-, 5-, and 12-month follow-ups. Recovery was defined as 30% reduction in low back pain-specific disability at follow-up compared with baseline and as absolute recovery if the score on the Quebec Back Pain Disability Scale (QBPDS) was ≤20 points at follow-up. Potential prognostic factors were identified using multivariable logistic regression analysis.
RESULTS: Mean patient-reported disability scores on the QBPDS ranged from 51.7 (SD=15.6) at baseline to 31.7 (SD=15.2), 31.1 (SD=18.2), and 29.1 (SD=20.0) at 2, 5, and 12 months, respectively. The prognostic factors identified for recovery at 5 and 12 months were younger age and high scores on disability and on the 36-Item Short-Form Health Survey (SF-36) (Physical and Mental Component Summaries) at baseline. In addition, at 5-month follow-up, a shorter duration of complaints was a positive predictor, and having no comorbidity and less pain at baseline were additional predictors at 12-month follow-up. LIMITATIONS: Missing values at 5- and 12-month follow-ups were 11.1% and 45.2%, respectively.
CONCLUSION: After multidisciplinary treatment, the course of disability in patients with CNSLBP continued to decline over a 12-month period. At 5- and 12-month follow-ups, prognostic factors were identified for a clinically relevant decrease in disability scores on the QBPDS.

Entities:  

Mesh:

Year:  2013        PMID: 23824781     DOI: 10.2522/ptj.20130076

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  10 in total

1.  [Periradicular infiltration therapy : Clinical indications, technique and results].

Authors:  B Oder; S Thurnher
Journal:  Radiologe       Date:  2015-10       Impact factor: 0.635

2.  Identifying Treatment Effect Modifiers in the STarT Back Trial: A Secondary Analysis.

Authors:  Jason M Beneciuk; Jonathan C Hill; Paul Campbell; Ebenezer Afolabi; Steven Z George; Kate M Dunn; Nadine E Foster
Journal:  J Pain       Date:  2016-10-17       Impact factor: 5.820

3.  Searching for success: Development of a combined patient-reported-outcome ("PRO") criterion for operationalizing success in multi-modal pain therapy.

Authors:  Carolin Donath; Lisa Dorscht; Elmar Graessel; Reinhard Sittl; Christoph Schoen
Journal:  BMC Health Serv Res       Date:  2015-07-17       Impact factor: 2.655

Review 4.  Prevention of occupational Back Pain.

Authors:  Sultan T Al-Otaibi
Journal:  J Family Community Med       Date:  2015 May-Aug

Review 5.  What is the role of lifestyle behaviour change associated with non-communicable disease risk in managing musculoskeletal health conditions with special reference to chronic pain?

Authors:  Elizabeth Dean; Anne Söderlund
Journal:  BMC Musculoskelet Disord       Date:  2015-04-13       Impact factor: 2.362

6.  Mixed-methods development of a new patient-reported outcome instrument for chronic low back pain: part 1-the Patient Assessment for Low Back Pain - Symptoms (PAL-S).

Authors:  Mona L Martin; Steven I Blum; Hiltrud Liedgens; Donald M Bushnell; Kelly P McCarrier; Noël V Hatley; Abhilasha Ramasamy; Rainer Freynhagen; Mark Wallace; Charles Argoff; Mariёlle Eerdekens; Maurits Kok; Donald L Patrick
Journal:  Pain       Date:  2018-06       Impact factor: 7.926

7.  Predictive factors of high societal costs among chronic low back pain patients.

Authors:  Elizabeth N Mutubuki; Mariette A Luitjens; Esther T Maas; Frank J P M Huygen; Raymond W J G Ostelo; Maurits W van Tulder; Johanna M van Dongen
Journal:  Eur J Pain       Date:  2019-10-10       Impact factor: 3.931

8.  Paraspinal Muscle Health is Related to Fibrogenic, Adipogenic, and Myogenic Gene Expression in Patients with Lumbar Spine Pathology.

Authors:  Brad Anderson; Angel Ordaz; Vinko Zlomislic; R Todd Allen; Steven R Garfin; Regula Schuepbach; Mazda Farshad; Simon Schenk; Samuel R Ward; Bahar Shahidi
Journal:  BMC Musculoskelet Disord       Date:  2022-06-24       Impact factor: 2.562

9.  Prevalence of Neuropathic Pain and Patient-Reported Outcomes in Korean Adults with Chronic Low Back Pain Resulting from Neuropathic Low Back Pain.

Authors:  Jin-Hwan Kim; Jae Taek Hong; Chong-Suh Lee; Keun-Su Kim; Kyung-Soo Suk; Jin-Hyok Kim; Ye-Soo Park; Bong-Soon Chang; Deuk Soo Jun; Young-Hoon Kim; Jung-Hee Lee; Woo-Kie Min; Jung-Sub Lee; Si-Young Park; In-Soo Oh; Jae-Young Hong; Hyun-Chul Shin; Woo-Kyung Kim; Joo-Han Kim; Jung-Kil Lee; In-Soo Kim; Yoon Ha; Soo-Bin Im; Sang Woo Kim; In-Ho Han; Jun-Jae Shin; Byeong Cheol Rim; Bo-Jeong Seo; Young-Joo Kim; Juneyoung Lee
Journal:  Asian Spine J       Date:  2017-12-07

10.  Prognostic Factors for Physical Functioning After Multidisciplinary Rehabilitation in Patients With Chronic Musculoskeletal Pain: A Systematic Review and Meta-Analysis.

Authors:  Elena Tseli; Katja Boersma; Britt-Marie Stålnacke; Paul Enthoven; Björn Gerdle; Björn O Äng; Wilhelmus J A Grooten
Journal:  Clin J Pain       Date:  2019-02       Impact factor: 3.442

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.